Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia

The European Journal of Neuroscience
Sara XapelliJ O Malva

Abstract

The neuroprotective effect of neuropeptide Y (NPY) receptor activation was investigated in organotypic mouse hippocampal slice cultures exposed to the glutamate receptor agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Exposure of 2-week-old slice cultures, derived from 7-day-old C57BL/6 mice, to 8 microm AMPA, for 24 h, induced degeneration of CA1 and CA3 pyramidal cells, as measured by cellular uptake of propidium iodide (PI). A significant neuroprotection, with a reduction of PI uptake in CA1 and CA3 pyramidal cell layers, was observed after incubation with a Y(2) receptor agonist [NPY(13-36), 300 nm]. This effect was sensitive to the presence of the selective Y(2) receptor antagonist (BIIE0246, 1 microm), but was not affected by addition of TrkB-Fc or by a neutralizing antibody against brain-derived neurotrophic factor (BDNF). Moreover, addition of a Y(1) receptor antagonist (BIBP3226, 1 microm) or a NPY-neutralizing antibody helped to disclose a neuroprotective role of endogenous NPY in CA1 region. Cultures exposed to 8 microm AMPA for 24 h, displayed, as measured by an enzyme-linked immunosorbent assay, a significant increase in BDNF. In such cultures there was an up-regulation of neuronal TrkB imm...Continue Reading

References

Apr 1, 1991·Journal of Neuroscience Methods·L StoppiniD Muller
Feb 1, 1987·The Journal of Physiology·W F ColmersQ J Pittman
Jul 4, 1998·Brain Research. Brain Research Reviews·T HökfeltJ H Walsh
Feb 12, 1999·Brain Research. Brain Research Protocols·J NorabergJ Zimmer
Apr 2, 1999·The European Journal of Neuroscience·R M Parker, H Herzog
Aug 9, 2001·Journal of Neuroscience Research·K NakajimaT Kurihara
Apr 2, 2002·Experimental Neurology·Helen E ScharfmanSusan D Croll
Mar 11, 2003·Experimental Biology and Medicine·Magnus M BerglundDonald R Gehlert
Apr 15, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ana P SilvaJoão O Malva
Mar 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cristina RichichiAnnamaria Vezzani
Jan 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Naoko Takayama, Hiroshi Ueda
Jan 22, 2005·Acta Pharmacologica Sinica·Yong-fei Wu, Sheng-bin Li
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Marcus J WirthPetra Wahle
Feb 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bin TuJ Victor Nadler
Jul 22, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Liliana BernardinoJens Zimmer
Aug 17, 2005·Current Drug Targets. CNS and Neurological Disorders·Ana P SilvaCláudia Cavadas

❮ Previous
Next ❯

Citations

Jun 20, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Megan M Varnum, Tsuneya Ikezu
Oct 7, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hagit CohenAleksander A Mathé
Oct 21, 2010·The Journal of Biological Chemistry·Raquel FerreiraJoão O Malva
Feb 2, 2012·Journal of Neuroinflammation·Jonathan VinetKnut Biber
Jul 16, 2014·Canadian Journal of Physiology and Pharmacology·Francesco AngelucciCarlo Caltagirone
Mar 26, 2009·Neuropeptides·Maria SmiałowskaMałgorzata Kajta
Oct 20, 2011·Journal of Neurochemistry·Raquel FerreiraJoão O Malva
Jul 30, 2015·Human Molecular Genetics·Joana Duarte-NevesLuís Pereira de Almeida
Aug 6, 2011·Neurobiology of Aging·Mickael DecressacAfsaneh Gaillard
Nov 5, 2013·Progress in Neurobiology·Ana Santos-CarvalhoCláudia Cavadas
Dec 22, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Catherine A OpereNajam A Sharif
Oct 23, 2010·Glia·Ida A K NilssonJeanette E Johansen
Mar 7, 2020·Journal of Cellular and Molecular Medicine·Kepeng OuAndrew D Dick
Sep 5, 2019·Frontiers in Neuroscience·Chunrong LiKangding Liu
Mar 22, 2019·Nature Reviews. Cardiology·Laura CalvilloGianfranco Parati
May 7, 2009·Current Opinion in Neurology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.